Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2023-05-03 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Board Meeting — DR. LAL PATH LABS LTD. has informed the Exchange about Board Meeting to be held on 11-May-2023 to consider financial statements for the period ended March 2023, Financial results/Divi…
Regulatory Filings
2023-05-03 English
Board Meeting — Financial Results/Dividend/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve audited financial results for the quarter and financial year ended March 31, 2023, and to consider recommending a final dividend. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures related to board meetings. The document is short (1920 characters) and serves as an announcement of an upcoming board meeting rather than containing any financial results or detailed reports. It does not contain actual financial data or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-05-03 English
Updates
Regulatory Filings
2023-04-26 English
Allotment of Securities
Share Issue/Capital Change Classification · 95% confidence The document is a short notice informing the stock exchanges about the allotment of equity shares under the company's Employee Stock Option Plan (ESOP) 2010. It mentions the increase in paid-up equity share capital due to this allotment. There are no financial statements, detailed financial data, or comprehensive reports included. The document is an announcement of a capital change related to share allotment under ESOP. According to the filing definitions, announcements regarding new share issues or capital changes fall under the category 'Share Issue/Capital Change' (SHA). The document length is short (1479 characters), and it is clearly an announcement rather than a full report or detailed filing.
2023-04-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2023. It is a short letter addressed to stock exchanges confirming regulatory compliance, signed by a compliance officer. There is no financial data, no detailed report, and the document is only providing a regulatory compliance confirmation. It does not fit into financial reports like Annual Report, Interim Report, or Earnings Release. It is not an announcement of voting results, board changes, or capital changes. It is a regulatory filing confirming compliance with SEBI regulations, which fits best under Regulatory Filings (RNS). The document length is short (1468 characters), and it is a certificate type filing, not a full report or announcement of a report publication.
2023-04-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice informing about the closure of the trading window as per SEBI (Prohibition of Insider Trading) Regulations, 2015. It mentions the trading window will be closed from April 1, 2023, until 48 hours after the announcement of audited financial results for the quarter and financial year ending March 31, 2023. The document is short (1640 characters) and serves as an announcement related to insider trading compliance rather than containing any financial data or report. It does not contain financial statements, management discussion, or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2023-03-31 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.